CeriBell, Inc. (CBLL)
NASDAQ: CBLL · Real-Time Price · USD
20.52
+0.30 (1.48%)
Feb 3, 2026, 3:32 PM EST - Market open
CeriBell Revenue
CeriBell had revenue of $22.59M in the quarter ending September 30, 2025, with 31.37% growth. This brings the company's revenue in the last twelve months to $82.81M, up 37.93% year-over-year. In the year 2024, CeriBell had annual revenue of $65.44M with 44.71% growth.
Revenue (ttm)
$82.81M
Revenue Growth
+37.93%
P/S Ratio
8.55
Revenue / Employee
$294,708
Employees
281
Market Cap
761.20M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 65.44M | 20.22M | 44.71% |
| Dec 31, 2023 | 45.23M | 19.30M | 74.47% |
| Dec 31, 2022 | 25.92M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCBLL News
- 21 days ago - CeriBell, Inc. (CBLL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution - GlobeNewsWire
- 4 weeks ago - Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution - GlobeNewsWire
- 2 months ago - Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates - GlobeNewsWire
- 2 months ago - Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 3 months ago - Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - GlobeNewsWire
- 3 months ago - CeriBell, Inc. (CBLL) Q3 2025 Earnings Call Transcript - Seeking Alpha